Component
Cystine
Cystine. Experimental scope belongs to the associated record.
30 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What it acts on
In eight healthy adults, adding 6.5 mg/kg/day cystine to a diet containing 5 mg/kg/day methionine did not significantly change methionine oxidation compared with the same low-methionine diet without cystine.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Six-day dietary periods followed by oral tracers and fasting/fed measurements on day seven.
- limitations
- This endpoint and regimen do not disprove every methionine-sparing effect or define current intake recommendations.
- nutrient_topic
- L-Cysteine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Cysteine
- plain_language
- A plausible nutrient-saving relationship was not detectable with this particular short-term measurement.
- primary_references
- Effect of cystine intake on methionine kinetics and oxidation determined with oral tracers of methionine and cysteine in healthy adults. · 1997 · https://pubmed.ncbi.nlm.nih.gov/9250106/ · DOI 10.1093/ajcn/66.2.283
L-Cysteine: sulfur allocation, redox supply and cross-nutrient mechanisms (2026-09-19) · lines 444–450
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Six-day dietary periods followed by oral tracers and fasting/fed measurements on day seven. · source_derived_draft · unverified_draft
## l-cysteine-methionine-sparing-limit A plausible nutrient-saving relationship was not detectable with this particular short-term measurement. In eight healthy adults, adding 6.5 mg/kg/day cystine to a diet containing 5 mg/kg/day methionine did not significantly change methionine oxidation compared with the same low-methionine diet without cystine. Model: Six-day dietary periods followed by oral tracers and fasting/fed measurements on day seven. Limitations: This endpoint and regimen do not disprove every methionine-sparing effect or define current intake recommendations. Evidence access: Primary abstract Effect of cystine intake on methionine kinetics and oxidation determined with oral tracers of methionine and cysteine in healthy adults. · 1997 · https://pubmed.ncbi.nlm.nih.gov/9250106/ · DOI 10.1093/ajcn/66.2.283
Complete structured claim and evidenceCarbon-13 cystine tracing showed labeling of glutathione and CoA over the experiment, including CoA labeling over 24 hours.
Experimental context and source evidence
- evidence_access
- Primary full text
- experimental_model
- Human PDAC stable-isotope tracing.
- limitations
- No labeling of taurine, lactate, citrate or glutamate was detected in these assays; that does not abolish those routes in other tissues.
- nutrient_topic
- L-Cysteine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Cysteine
- plain_language
- Cysteine-derived material entered more than one protective metabolic pool.
- primary_references
- Cysteine depletion induces pancreatic tumor ferroptosis in mice. · 2020 · https://pubmed.ncbi.nlm.nih.gov/32241947/ · DOI 10.1126/science.aaw9872
L-Cysteine: sulfur allocation, redox supply and cross-nutrient mechanisms (2026-09-19) · lines 188–194
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human PDAC stable-isotope tracing. · source_derived_draft · unverified_draft
## l-cysteine-pdac-carbon-tracing Cysteine-derived material entered more than one protective metabolic pool. Carbon-13 cystine tracing showed labeling of glutathione and CoA over the experiment, including CoA labeling over 24 hours. Model: Human PDAC stable-isotope tracing. Limitations: No labeling of taurine, lactate, citrate or glutamate was detected in these assays; that does not abolish those routes in other tissues. Evidence access: Primary full text Cysteine depletion induces pancreatic tumor ferroptosis in mice. · 2020 · https://pubmed.ncbi.nlm.nih.gov/32241947/ · DOI 10.1126/science.aaw9872
Complete structured claim and evidenceCystine starvation induced lipid oxidation and ferroptosis in four of five tested human PDAC cell lines.
Experimental context and source evidence
- availability_state
- nutrient_deficiency Imported condition classification; unverified.
- evidence_access
- Primary full text
- experimental_model
- Human pancreatic cancer cultures; nutrient withdrawal, oxidation and viability assays.
- limitations
- Culture starvation is not dietary treatment; one of the tested lines differed.
- nutrient_topic
- L-Cysteine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Cysteine
- plain_language
- Dependence on external sulfur varied between cancer-cell models.
- primary_references
- Cysteine depletion induces pancreatic tumor ferroptosis in mice. · 2020 · https://pubmed.ncbi.nlm.nih.gov/32241947/ · DOI 10.1126/science.aaw9872
- trigger_kind
- nutrient_deficiency Imported condition classification; unverified.
L-Cysteine: sulfur allocation, redox supply and cross-nutrient mechanisms (2026-09-19) · lines 180–186
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human pancreatic cancer cultures; nutrient withdrawal, oxidation and viability assays. · source_derived_draft · unverified_draft
## l-cysteine-pdac-cystine-withdrawal Dependence on external sulfur varied between cancer-cell models. Cystine starvation induced lipid oxidation and ferroptosis in four of five tested human PDAC cell lines. Model: Human pancreatic cancer cultures; nutrient withdrawal, oxidation and viability assays. Limitations: Culture starvation is not dietary treatment; one of the tested lines differed. Evidence access: Primary full text Cysteine depletion induces pancreatic tumor ferroptosis in mice. · 2020 · https://pubmed.ncbi.nlm.nih.gov/32241947/ · DOI 10.1126/science.aaw9872
Complete structured claim and evidence
What acts on it
Cell-derived DHLA reduced extracellular cystine to cysteine in the tested cultures.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/ala-research/9288403.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "6a14c857d89c580ffe8866d7e5f06658dcc806429ae3a4b8ad4bd096f664a2e2", "start_char": 0, "end_char": 1497, "text_sha256": "6a14c857d89c580ffe8866d7e5f06658dcc806429ae3a4b8ad4bd096f664a2e2"}
- experimental_model
- Cell-culture thiol transport and glutathione experiments
- exposure
- Lipoic acid/DHLA treatment and extracellular thiol measurements
- limitations
- Cell-type and extracellular-substrate dependence; no demonstration of general methylation-vitamin depletion.
- nutrient_topic
- Alpha-lipoic acid research collection; topical membership is not evidence of a direct dietary effect. · Lipoic acid
- organism
- Human, rat and mouse cells as specified
- plain_language
- Reduced lipoic acid made a glutathione building block more available.
- primary_references
- [ala-p9288403] Lipoic acid increases de novo synthesis of cellular glutathione by improving cystine utilization. (1997). https://pubmed.ncbi.nlm.nih.gov/9288403/ DOI: 10.1002/biof.5520060303
- tissue_or_cell_type
- Human lymphocytes, Jurkat cells and erythrocytes; rat C6 and mouse NB41A3 cells
Alpha-lipoic acid: cofactor assembly, redox signaling and nutrient interactions (2026-09-17) · lines 793–804
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Cell-culture thiol transport and glutathione experiments · source_derived_draft · unverified_draft
### ala-dhla-cystine-cysteine Cell-derived DHLA reduced extracellular cystine to cysteine in the tested cultures. Condition category: normal nutrient_topic: Alpha-lipoic acid research collection; topical membership is not evidence of a direct dietary effect. plain_language: Reduced lipoic acid made a glutathione building block more available. organism: Human, rat and mouse cells as specified tissue_or_cell_type: Human lymphocytes, Jurkat cells and erythrocytes; rat C6 and mouse NB41A3 cells experimental_model: Cell-culture thiol transport and glutathione experiments limitations: Cell-type and extracellular-substrate dependence; no demonstration of general methylation-vitamin depletion. exposure: Lipoic acid/DHLA treatment and extracellular thiol measurements evidence_span: {"source_cache": "artifacts/ala-research/9288403.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "6a14c857d89c580ffe8866d7e5f06658dcc806429ae3a4b8ad4bd096f664a2e2", "start_char": 0, "end_char": 1497, "text_sha256": "6a14c857d89c580ffe8866d7e5f06658dcc806429ae3a4b8ad4bd096f664a2e2"} [ala-p9288403] Lipoic acid increases de novo synthesis of cellular glutathione by improving cystine utilization. (1997). https://pubmed.ncbi.nlm.nih.gov/9288403/ DOI: 10.1002/biof.5520060303
Complete structured claim and evidenceHuman cystinosin structures and functional assays support proton-coupled cystine export from the lysosomal lumen toward the cytosol.
Experimental context and source evidence
- evidence_access
- Primary full text
- experimental_model
- Human CTNS crystallography, cryo-EM, transport and spectroscopic assays.
- limitations
- Transport was assayed with engineered constructs; normal dietary intake does not bypass a defective lysosomal exporter.
- nutrient_topic
- L-Cysteine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Cysteine
- plain_language
- Protein recycling supplies sulfur only if its breakdown products can leave the lysosome.
- primary_references
- Structure and mechanism of human cystine exporter cystinosin. · 2022 · https://pubmed.ncbi.nlm.nih.gov/36113465/ · DOI 10.1016/j.cell.2022.08.020
- transport_effect
- raises Recorded as proton-coupled export from the lysosomal lumen toward the cytosol. The lysosomal pool falls in the same step.
- transport_pool
- cytosolic cystine Recorded as proton-coupled export from the lysosomal lumen toward the cytosol. The lysosomal pool falls in the same step.
L-Cysteine: sulfur allocation, redox supply and cross-nutrient mechanisms (2026-09-19) · lines 28–34
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human CTNS crystallography, cryo-EM, transport and spectroscopic assays. · source_derived_draft · unverified_draft
## l-cysteine-lysosomal-export Protein recycling supplies sulfur only if its breakdown products can leave the lysosome. Human cystinosin structures and functional assays support proton-coupled cystine export from the lysosomal lumen toward the cytosol. Model: Human CTNS crystallography, cryo-EM, transport and spectroscopic assays. Limitations: Transport was assayed with engineered constructs; normal dietary intake does not bypass a defective lysosomal exporter. Evidence access: Primary full text Structure and mechanism of human cystine exporter cystinosin. · 2022 · https://pubmed.ncbi.nlm.nih.gov/36113465/ · DOI 10.1016/j.cell.2022.08.020
Complete structured claim and evidenceHuman hxCTb required 4F2hc for sodium-independent cystine/glutamate transport in oocytes.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/glutathione-research/11406111.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "e7118afd8c6055ed926ee24dbb7a07538f676163d605115ae0d32d49fbef7fdc", "start_char": 0, "end_char": 1364, "text_sha256": "e7118afd8c6055ed926ee24dbb7a07538f676163d605115ae0d32d49fbef7fdc"}
- experimental_model
- Human xCT expression and oxidative-stress response
- exposure
- hxCTb with 4F2hc; diethyl maleate challenge
- limitations
- Sodium independence belongs to this transporter; other cysteine-entry routes differ.
- nutrient_topic
- Glutathione research collection; topical membership is not evidence of a direct dietary effect. · GSH
- organism
- Human transporter; Xenopus expression host
- plain_language
- The precursor-entry route depends on two transporter subunits.
- primary_references
- [glutathione-p11406111] Human cystine/glutamate transporter: cDNA cloning and upregulation by oxidative stress in glioma cells. (2001). https://pubmed.ncbi.nlm.nih.gov/11406111/ DOI: 10.1016/s0005-2736(01)00338-8
- tissue_or_cell_type
- Oocyte membranes and human U87 glioma cells
- transport_effect
- depends The record names the cystine/glutamate exchange pair and the 4F2hc requirement, not which way cystine crossed.
- transport_pool
- the cytosol across the plasma membrane The record names the cystine/glutamate exchange pair and the 4F2hc requirement, not which way cystine crossed.
Glutathione: metabolism, signaling and nutrient connections (2026-09-17) · lines 736–747
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Human xCT expression and oxidative-stress response · source_derived_draft · unverified_draft
### glutathione-xct-cystine Human hxCTb required 4F2hc for sodium-independent cystine/glutamate transport in oocytes. Condition category: normal nutrient_topic: Glutathione research collection; topical membership is not evidence of a direct dietary effect. plain_language: The precursor-entry route depends on two transporter subunits. organism: Human transporter; Xenopus expression host tissue_or_cell_type: Oocyte membranes and human U87 glioma cells experimental_model: Human xCT expression and oxidative-stress response limitations: Sodium independence belongs to this transporter; other cysteine-entry routes differ. exposure: hxCTb with 4F2hc; diethyl maleate challenge evidence_span: {"source_cache": "artifacts/glutathione-research/11406111.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "e7118afd8c6055ed926ee24dbb7a07538f676163d605115ae0d32d49fbef7fdc", "start_char": 0, "end_char": 1364, "text_sha256": "e7118afd8c6055ed926ee24dbb7a07538f676163d605115ae0d32d49fbef7fdc"} [glutathione-p11406111] Human cystine/glutamate transporter: cDNA cloning and upregulation by oxidative stress in glioma cells. (2001). https://pubmed.ncbi.nlm.nih.gov/11406111/ DOI: 10.1016/s0005-2736(01)00338-8
Complete structured claim and evidence
Where it participates (unsigned role)
The cystine-theanine mixture reduced diarrhea in the mouse chemotherapy model.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/theanine-research/34922485.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "5828410d2c083fec47a3c7e1907b801a2dc616dbbb7e5ed36e59d503bceeb282", "start_char": 0, "end_char": 1703, "text_sha256": "5828410d2c083fec47a3c7e1907b801a2dc616dbbb7e5ed36e59d503bceeb282"}
- experimental_model
- Chemotherapy-associated intestinal injury experiment
- exposure
- Cystine plus theanine during 5-fluorouracil exposure
- limitations
- Combination product, not isolated theanine. Preservation of antitumor activity in the tested model does not establish compatibility with every human chemotherapy regimen.
- nutrient_topic
- L-Theanine research collection; topical membership is not evidence of a direct dietary effect. · L-Theanine
- organism
- Mice
- plain_language
- This result belongs to the tested two-ingredient mixture and its chemotherapy context.
- primary_references
- [theanine-p34922485] Oral administration of cystine and theanine attenuates 5-fluorouracil-induced intestinal mucositis and diarrhea by suppressing both glutathione level decrease and ROS production in the small intestine of mucositis mouse model. (2021). https://pubmed.ncbi.nlm.nih.gov/34922485/ DOI: 10.1186/s12885-021-09057-z
- tissue_or_cell_type
- Intestinal redox balance and crypt injury
L-Theanine: metabolism, neural signaling, nutrient connections and human outcomes (2026-09-17) · lines 783–794
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Chemotherapy-associated intestinal injury experiment · source_derived_draft · unverified_draft
### theanine-ct-diarrhea The cystine-theanine mixture reduced diarrhea in the mouse chemotherapy model. Condition category: normal nutrient_topic: L-Theanine research collection; topical membership is not evidence of a direct dietary effect. plain_language: This result belongs to the tested two-ingredient mixture and its chemotherapy context. organism: Mice tissue_or_cell_type: Intestinal redox balance and crypt injury experimental_model: Chemotherapy-associated intestinal injury experiment limitations: Combination product, not isolated theanine. Preservation of antitumor activity in the tested model does not establish compatibility with every human chemotherapy regimen. exposure: Cystine plus theanine during 5-fluorouracil exposure evidence_span: {"source_cache": "artifacts/theanine-research/34922485.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "5828410d2c083fec47a3c7e1907b801a2dc616dbbb7e5ed36e59d503bceeb282", "start_char": 0, "end_char": 1703, "text_sha256": "5828410d2c083fec47a3c7e1907b801a2dc616dbbb7e5ed36e59d503bceeb282"} [theanine-p34922485] Oral administration of cystine and theanine attenuates 5-fluorouracil-induced intestinal mucositis and diarrhea by suppressing both glutathione level decrease and ROS production in the small intestine of mucositis mouse model. (2021). https://pubmed.ncbi.nlm.nih.gov/34922485/ DOI: 10.1186/s12885-021-09057-z
Complete structured claim and evidenceThe cystine-theanine mixture restored the intestinal GSH/GSSG ratio during 5-fluorouracil exposure.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/theanine-research/34922485.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "5828410d2c083fec47a3c7e1907b801a2dc616dbbb7e5ed36e59d503bceeb282", "start_char": 0, "end_char": 1703, "text_sha256": "5828410d2c083fec47a3c7e1907b801a2dc616dbbb7e5ed36e59d503bceeb282"}
- experimental_model
- Chemotherapy-associated intestinal injury experiment
- exposure
- Cystine plus theanine during 5-fluorouracil exposure
- limitations
- Combination product, not isolated theanine. Preservation of antitumor activity in the tested model does not establish compatibility with every human chemotherapy regimen.
- nutrient_topic
- L-Theanine research collection; topical membership is not evidence of a direct dietary effect. · L-Theanine
- organism
- Mice
- plain_language
- This result belongs to the tested two-ingredient mixture and its chemotherapy context.
- primary_references
- [theanine-p34922485] Oral administration of cystine and theanine attenuates 5-fluorouracil-induced intestinal mucositis and diarrhea by suppressing both glutathione level decrease and ROS production in the small intestine of mucositis mouse model. (2021). https://pubmed.ncbi.nlm.nih.gov/34922485/ DOI: 10.1186/s12885-021-09057-z
- tissue_or_cell_type
- Intestinal redox balance and crypt injury
L-Theanine: metabolism, neural signaling, nutrient connections and human outcomes (2026-09-17) · lines 757–768
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Chemotherapy-associated intestinal injury experiment · source_derived_draft · unverified_draft
### theanine-ct-redox The cystine-theanine mixture restored the intestinal GSH/GSSG ratio during 5-fluorouracil exposure. Condition category: normal nutrient_topic: L-Theanine research collection; topical membership is not evidence of a direct dietary effect. plain_language: This result belongs to the tested two-ingredient mixture and its chemotherapy context. organism: Mice tissue_or_cell_type: Intestinal redox balance and crypt injury experimental_model: Chemotherapy-associated intestinal injury experiment limitations: Combination product, not isolated theanine. Preservation of antitumor activity in the tested model does not establish compatibility with every human chemotherapy regimen. exposure: Cystine plus theanine during 5-fluorouracil exposure evidence_span: {"source_cache": "artifacts/theanine-research/34922485.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "5828410d2c083fec47a3c7e1907b801a2dc616dbbb7e5ed36e59d503bceeb282", "start_char": 0, "end_char": 1703, "text_sha256": "5828410d2c083fec47a3c7e1907b801a2dc616dbbb7e5ed36e59d503bceeb282"} [theanine-p34922485] Oral administration of cystine and theanine attenuates 5-fluorouracil-induced intestinal mucositis and diarrhea by suppressing both glutathione level decrease and ROS production in the small intestine of mucositis mouse model. (2021). https://pubmed.ncbi.nlm.nih.gov/34922485/ DOI: 10.1186/s12885-021-09057-z
Complete structured claim and evidenceThe cystine-theanine mixture reduced reactive oxygen species in intestinal crypts.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/theanine-research/34922485.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "5828410d2c083fec47a3c7e1907b801a2dc616dbbb7e5ed36e59d503bceeb282", "start_char": 0, "end_char": 1703, "text_sha256": "5828410d2c083fec47a3c7e1907b801a2dc616dbbb7e5ed36e59d503bceeb282"}
- experimental_model
- Chemotherapy-associated intestinal injury experiment
- exposure
- Cystine plus theanine during 5-fluorouracil exposure
- limitations
- Combination product, not isolated theanine. Preservation of antitumor activity in the tested model does not establish compatibility with every human chemotherapy regimen.
- nutrient_topic
- L-Theanine research collection; topical membership is not evidence of a direct dietary effect. · L-Theanine
- organism
- Mice
- plain_language
- This result belongs to the tested two-ingredient mixture and its chemotherapy context.
- primary_references
- [theanine-p34922485] Oral administration of cystine and theanine attenuates 5-fluorouracil-induced intestinal mucositis and diarrhea by suppressing both glutathione level decrease and ROS production in the small intestine of mucositis mouse model. (2021). https://pubmed.ncbi.nlm.nih.gov/34922485/ DOI: 10.1186/s12885-021-09057-z
- tissue_or_cell_type
- Intestinal redox balance and crypt injury
L-Theanine: metabolism, neural signaling, nutrient connections and human outcomes (2026-09-17) · lines 770–781
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Chemotherapy-associated intestinal injury experiment · source_derived_draft · unverified_draft
### theanine-ct-ros The cystine-theanine mixture reduced reactive oxygen species in intestinal crypts. Condition category: normal nutrient_topic: L-Theanine research collection; topical membership is not evidence of a direct dietary effect. plain_language: This result belongs to the tested two-ingredient mixture and its chemotherapy context. organism: Mice tissue_or_cell_type: Intestinal redox balance and crypt injury experimental_model: Chemotherapy-associated intestinal injury experiment limitations: Combination product, not isolated theanine. Preservation of antitumor activity in the tested model does not establish compatibility with every human chemotherapy regimen. exposure: Cystine plus theanine during 5-fluorouracil exposure evidence_span: {"source_cache": "artifacts/theanine-research/34922485.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "5828410d2c083fec47a3c7e1907b801a2dc616dbbb7e5ed36e59d503bceeb282", "start_char": 0, "end_char": 1703, "text_sha256": "5828410d2c083fec47a3c7e1907b801a2dc616dbbb7e5ed36e59d503bceeb282"} [theanine-p34922485] Oral administration of cystine and theanine attenuates 5-fluorouracil-induced intestinal mucositis and diarrhea by suppressing both glutathione level decrease and ROS production in the small intestine of mucositis mouse model. (2021). https://pubmed.ncbi.nlm.nih.gov/34922485/ DOI: 10.1186/s12885-021-09057-z
Complete structured claim and evidenceCystine plus theanine increased splenic gamma-glutamylcysteine synthetase mRNA in aged mice.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/theanine-research/19940390.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "1fddde12da03a7fd75a7415e00207f4ac2c34c9215ab504ea1b3735e36db3a26", "start_char": 0, "end_char": 1786, "text_sha256": "1fddde12da03a7fd75a7415e00207f4ac2c34c9215ab504ea1b3735e36db3a26"}
- experimental_model
- Aged-animal influenza challenge and immunization
- exposure
- Oral cystine plus theanine before influenza challenge
- limitations
- Animal combination study; enzyme-subunit identity is not inferred from the generic gamma-glutamylcysteine synthetase wording. No proof theanine alone prevents human influenza.
- nutrient_topic
- L-Theanine research collection; topical membership is not evidence of a direct dietary effect. · L-Theanine
- organism
- Aged mice
- plain_language
- Precursor supplementation was linked to expression of glutathione-synthesis machinery, not proof of every downstream antioxidant benefit.
- primary_references
- [theanine-p19940390] Combined administration of (L)-cystine and (L)-theanine enhances immune functions and protects against influenza virus infection in aged mice. (2010). https://pubmed.ncbi.nlm.nih.gov/19940390/ DOI: 10.1292/jvms.09-0067
- tissue_or_cell_type
- Spleen and lung
L-Theanine: metabolism, neural signaling, nutrient connections and human outcomes (2026-09-17) · lines 796–807
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Aged-animal influenza challenge and immunization · source_derived_draft · unverified_draft
### theanine-ct-splenic-expression Cystine plus theanine increased splenic gamma-glutamylcysteine synthetase mRNA in aged mice. Condition category: normal nutrient_topic: L-Theanine research collection; topical membership is not evidence of a direct dietary effect. plain_language: Precursor supplementation was linked to expression of glutathione-synthesis machinery, not proof of every downstream antioxidant benefit. organism: Aged mice tissue_or_cell_type: Spleen and lung experimental_model: Aged-animal influenza challenge and immunization limitations: Animal combination study; enzyme-subunit identity is not inferred from the generic gamma-glutamylcysteine synthetase wording. No proof theanine alone prevents human influenza. exposure: Oral cystine plus theanine before influenza challenge evidence_span: {"source_cache": "artifacts/theanine-research/19940390.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "1fddde12da03a7fd75a7415e00207f4ac2c34c9215ab504ea1b3735e36db3a26", "start_char": 0, "end_char": 1786, "text_sha256": "1fddde12da03a7fd75a7415e00207f4ac2c34c9215ab504ea1b3735e36db3a26"} [theanine-p19940390] Combined administration of (L)-cystine and (L)-theanine enhances immune functions and protects against influenza virus infection in aged mice. (2010). https://pubmed.ncbi.nlm.nih.gov/19940390/ DOI: 10.1292/jvms.09-0067
Complete structured claim and evidenceBlocking AMPK activation increased cell death under cysteine-deficient conditions in the tested cultures.
Experimental context and source evidence
- availability_state
- nutrient_deficiency Imported condition classification; unverified.
- evidence_access
- Primary abstract
- experimental_model
- Human-cell nutrient-withdrawal experiments with AMPK-pathway perturbation.
- limitations
- This is an adaptive response under culture deprivation, not evidence that chronic dietary deprivation is beneficial.
- nutrient_topic
- L-Cysteine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Cysteine
- plain_language
- The response to scarcity helped cells survive it.
- primary_references
- CARS senses cysteine deprivation to activate AMPK for cell survival. · 2021 · https://pubmed.ncbi.nlm.nih.gov/34472622/ · DOI 10.15252/embj.2021108028
- trigger_kind
- nutrient_deficiency Imported condition classification; unverified.
L-Cysteine: sulfur allocation, redox supply and cross-nutrient mechanisms (2026-09-19) · lines 148–154
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human-cell nutrient-withdrawal experiments with AMPK-pathway perturbation. · source_derived_draft · unverified_draft
## l-cysteine-ampk-adaptation The response to scarcity helped cells survive it. Blocking AMPK activation increased cell death under cysteine-deficient conditions in the tested cultures. Model: Human-cell nutrient-withdrawal experiments with AMPK-pathway perturbation. Limitations: This is an adaptive response under culture deprivation, not evidence that chronic dietary deprivation is beneficial. Evidence access: Primary abstract CARS senses cysteine deprivation to activate AMPK for cell survival. · 2021 · https://pubmed.ncbi.nlm.nih.gov/34472622/ · DOI 10.15252/embj.2021108028
Complete structured claim and evidenceCysteine scarcity promoted CARS association with AMPK gamma-2, whereas cysteine inhibited this association in the reported experiments.
Experimental context and source evidence
- availability_state
- nutrient_deficiency Imported condition classification; unverified.
- evidence_access
- Primary abstract and indexed primary figure descriptions
- experimental_model
- Human 293T-centered cell and binding experiments; extracellular cystine withdrawal or 0–200 micromolar titration for eight hours.
- limitations
- Medium cystine manipulation changes intracellular cysteine; do not relabel it as a controlled human dietary intake.
- nutrient_topic
- L-Cysteine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Cysteine
- plain_language
- A protein-synthesis enzyme also helped sense the availability of its amino acid.
- primary_references
- CARS senses cysteine deprivation to activate AMPK for cell survival. · 2021 · https://pubmed.ncbi.nlm.nih.gov/34472622/ · DOI 10.15252/embj.2021108028
- trigger_kind
- nutrient_deficiency Imported condition classification; unverified.
L-Cysteine: sulfur allocation, redox supply and cross-nutrient mechanisms (2026-09-19) · lines 132–138
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human 293T-centered cell and binding experiments; extracellular cystine withdrawal or 0–200 micromolar titration for eight hours. · source_derived_draft · unverified_draft
## l-cysteine-cars-sensing A protein-synthesis enzyme also helped sense the availability of its amino acid. Cysteine scarcity promoted CARS association with AMPK gamma-2, whereas cysteine inhibited this association in the reported experiments. Model: Human 293T-centered cell and binding experiments; extracellular cystine withdrawal or 0–200 micromolar titration for eight hours. Limitations: Medium cystine manipulation changes intracellular cysteine; do not relabel it as a controlled human dietary intake. Evidence access: Primary abstract and indexed primary figure descriptions CARS senses cysteine deprivation to activate AMPK for cell survival. · 2021 · https://pubmed.ncbi.nlm.nih.gov/34472622/ · DOI 10.15252/embj.2021108028
Complete structured claim and evidenceMutating human cystinosin K273, K280, D305, W138, N166 or F142 abolished cystine transport in the reported assays.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_access
- Primary full text
- experimental_model
- Human CTNS site-directed mutagenesis and transport measurements.
- limitations
- Experimental mutations and disease-associated variants are not a dietary deficiency.
- nutrient_topic
- L-Cysteine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Cysteine
- plain_language
- A correctly located transporter may still fail to recognize or move its substrate.
- primary_references
- Structure and mechanism of human cystine exporter cystinosin. · 2022 · https://pubmed.ncbi.nlm.nih.gov/36113465/ · DOI 10.1016/j.cell.2022.08.020
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
L-Cysteine: sulfur allocation, redox supply and cross-nutrient mechanisms (2026-09-19) · lines 36–42
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human CTNS site-directed mutagenesis and transport measurements. · source_derived_draft · unverified_draft
## l-cysteine-ctns-binding-residues A correctly located transporter may still fail to recognize or move its substrate. Mutating human cystinosin K273, K280, D305, W138, N166 or F142 abolished cystine transport in the reported assays. Model: Human CTNS site-directed mutagenesis and transport measurements. Limitations: Experimental mutations and disease-associated variants are not a dietary deficiency. Evidence access: Primary full text Structure and mechanism of human cystine exporter cystinosin. · 2022 · https://pubmed.ncbi.nlm.nih.gov/36113465/ · DOI 10.1016/j.cell.2022.08.020
Complete structured claim and evidenceD346N substitution abolished the pH-dependent conformational switch; the authors proposed D346 as a key protonation site controlling human cystinosin transitions.
Experimental context and source evidence
- evidence_access
- Primary full text
- experimental_model
- Human CTNS mutagenesis and double electron–electron resonance spectroscopy at pH 5.2 and 7.4.
- limitations
- A structure-supported protonation model is not a demonstrated effect of changing dietary acid or mineral intake.
- nutrient_topic
- L-Cysteine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Cysteine
- plain_language
- The transporter couples substrate movement to an acidic compartment.
- primary_references
- Structure and mechanism of human cystine exporter cystinosin. · 2022 · https://pubmed.ncbi.nlm.nih.gov/36113465/ · DOI 10.1016/j.cell.2022.08.020
L-Cysteine: sulfur allocation, redox supply and cross-nutrient mechanisms (2026-09-19) · lines 44–50
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human CTNS mutagenesis and double electron–electron resonance spectroscopy at pH 5.2 and 7.4. · source_derived_draft · unverified_draft
## l-cysteine-ctns-proton-switch The transporter couples substrate movement to an acidic compartment. D346N substitution abolished the pH-dependent conformational switch; the authors proposed D346 as a key protonation site controlling human cystinosin transitions. Model: Human CTNS mutagenesis and double electron–electron resonance spectroscopy at pH 5.2 and 7.4. Limitations: A structure-supported protonation model is not a demonstrated effect of changing dietary acid or mineral intake. Evidence access: Primary full text Structure and mechanism of human cystine exporter cystinosin. · 2022 · https://pubmed.ncbi.nlm.nih.gov/36113465/ · DOI 10.1016/j.cell.2022.08.020
Complete structured claim and evidenceThe human CTNS N288K variant altered conformation and suppressed engagement with Ragulator–Rag, linking transporter state with a nutrient-signaling complex.
Experimental context and source evidence
- evidence_access
- Primary full text
- experimental_model
- Human cystinosin cryo-EM and interaction experiments.
- limitations
- This does not demonstrate that oral cysteine directly activates mTORC1.
- nutrient_topic
- L-Cysteine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Cysteine
- plain_language
- Transport machinery can also affect how the cell senses nutrient availability.
- primary_references
- Structure and mechanism of human cystine exporter cystinosin. · 2022 · https://pubmed.ncbi.nlm.nih.gov/36113465/ · DOI 10.1016/j.cell.2022.08.020
L-Cysteine: sulfur allocation, redox supply and cross-nutrient mechanisms (2026-09-19) · lines 52–58
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human cystinosin cryo-EM and interaction experiments. · source_derived_draft · unverified_draft
## l-cysteine-ctns-ragulator Transport machinery can also affect how the cell senses nutrient availability. The human CTNS N288K variant altered conformation and suppressed engagement with Ragulator–Rag, linking transporter state with a nutrient-signaling complex. Model: Human cystinosin cryo-EM and interaction experiments. Limitations: This does not demonstrate that oral cysteine directly activates mTORC1. Evidence access: Primary full text Structure and mechanism of human cystine exporter cystinosin. · 2022 · https://pubmed.ncbi.nlm.nih.gov/36113465/ · DOI 10.1016/j.cell.2022.08.020
Complete structured claim and evidenceHigh SLC7A11-mediated cystine uptake increased reliance on glucose and the pentose phosphate pathway; glucose deprivation depleted NADPH and promoted intracellular disulfide accumulation.
Experimental context and source evidence
- availability_state
- nutrient_deficiency Imported condition classification; unverified.
- evidence_access
- Primary full text
- experimental_model
- Human cancer-cell transporter manipulation, glucose withdrawal and metabolic assays.
- limitations
- Complete glucose withdrawal in culture is not ordinary fasting or dietary carbohydrate restriction.
- nutrient_topic
- L-Cysteine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Cysteine
- plain_language
- Importing more oxidized nutrient also creates more work for the reducing system.
- primary_references
- Cystine transporter regulation of pentose phosphate pathway dependency and disulfide stress exposes a targetable metabolic vulnerability in cancer. · 2020 · https://pubmed.ncbi.nlm.nih.gov/32231310/ · DOI 10.1038/s41556-020-0496-x
- trigger_kind
- nutrient_deficiency Imported condition classification; unverified.
L-Cysteine: sulfur allocation, redox supply and cross-nutrient mechanisms (2026-09-19) · lines 236–242
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human cancer-cell transporter manipulation, glucose withdrawal and metabolic assays. · source_derived_draft · unverified_draft
## l-cysteine-cystine-nadph-demand Importing more oxidized nutrient also creates more work for the reducing system. High SLC7A11-mediated cystine uptake increased reliance on glucose and the pentose phosphate pathway; glucose deprivation depleted NADPH and promoted intracellular disulfide accumulation. Model: Human cancer-cell transporter manipulation, glucose withdrawal and metabolic assays. Limitations: Complete glucose withdrawal in culture is not ordinary fasting or dietary carbohydrate restriction. Evidence access: Primary full text Cystine transporter regulation of pentose phosphate pathway dependency and disulfide stress exposes a targetable metabolic vulnerability in cancer. · 2020 · https://pubmed.ncbi.nlm.nih.gov/32231310/ · DOI 10.1038/s41556-020-0496-x
Complete structured claim and evidencePreventing cystine uptake or removing cystine relieved the disulfide stress associated with glucose deprivation in SLC7A11-high cells.
Experimental context and source evidence
- availability_state
- nutrient_deficiency Imported condition classification; unverified.
- evidence_access
- Primary full text
- experimental_model
- Human cancer-cell glucose/cystine manipulation.
- limitations
- This is distinct from cystine-withdrawal ferroptosis under other conditions; no universal benefit of removing cystine is implied.
- nutrient_topic
- L-Cysteine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Cysteine
- plain_language
- Reducing the incoming load helped when the cell could not process it.
- primary_references
- Cystine transporter regulation of pentose phosphate pathway dependency and disulfide stress exposes a targetable metabolic vulnerability in cancer. · 2020 · https://pubmed.ncbi.nlm.nih.gov/32231310/ · DOI 10.1038/s41556-020-0496-x
- trigger_kind
- nutrient_deficiency Imported condition classification; unverified.
L-Cysteine: sulfur allocation, redox supply and cross-nutrient mechanisms (2026-09-19) · lines 244–250
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human cancer-cell glucose/cystine manipulation. · source_derived_draft · unverified_draft
## l-cysteine-cystine-reduction-rescue Reducing the incoming load helped when the cell could not process it. Preventing cystine uptake or removing cystine relieved the disulfide stress associated with glucose deprivation in SLC7A11-high cells. Model: Human cancer-cell glucose/cystine manipulation. Limitations: This is distinct from cystine-withdrawal ferroptosis under other conditions; no universal benefit of removing cystine is implied. Evidence access: Primary full text Cystine transporter regulation of pentose phosphate pathway dependency and disulfide stress exposes a targetable metabolic vulnerability in cancer. · 2020 · https://pubmed.ncbi.nlm.nih.gov/32231310/ · DOI 10.1038/s41556-020-0496-x
Complete structured claim and evidenceGlucose starvation of SLC7A11-high human cancer cells induced abnormal disulfide bonding in actin-cytoskeleton proteins, F-actin collapse and disulfidptosis, distinct from apoptosis and ferroptosis.
Experimental context and source evidence
- availability_state
- nutrient_deficiency Imported condition classification; unverified.
- evidence_access
- Primary abstract and primary publisher figure descriptions
- experimental_model
- Human cancer cultures, chemical proteomics and cell-biological assays.
- limitations
- Experimental deprivation; do not infer this occurs whenever blood glucose falls modestly.
- nutrient_topic
- L-Cysteine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Cysteine
- plain_language
- The damage involved cross-linked structural proteins rather than the same lipid-peroxide pathway.
- primary_references
- Actin cytoskeleton vulnerability to disulfide stress mediates disulfidptosis. · 2023 · https://pubmed.ncbi.nlm.nih.gov/36747082/ · DOI 10.1038/s41556-023-01091-2
- trigger_kind
- nutrient_deficiency Imported condition classification; unverified.
L-Cysteine: sulfur allocation, redox supply and cross-nutrient mechanisms (2026-09-19) · lines 252–258
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human cancer cultures, chemical proteomics and cell-biological assays. · source_derived_draft · unverified_draft
## l-cysteine-disulfidptosis-actin The damage involved cross-linked structural proteins rather than the same lipid-peroxide pathway. Glucose starvation of SLC7A11-high human cancer cells induced abnormal disulfide bonding in actin-cytoskeleton proteins, F-actin collapse and disulfidptosis, distinct from apoptosis and ferroptosis. Model: Human cancer cultures, chemical proteomics and cell-biological assays. Limitations: Experimental deprivation; do not infer this occurs whenever blood glucose falls modestly. Evidence access: Primary abstract and primary publisher figure descriptions Actin cytoskeleton vulnerability to disulfide stress mediates disulfidptosis. · 2023 · https://pubmed.ncbi.nlm.nih.gov/36747082/ · DOI 10.1038/s41556-023-01091-2
Complete structured claim and evidenceDeleting Slc7a11 in established genetically engineered mouse PDAC induced tumor-selective ferroptosis and inhibited growth.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_access
- Primary full text
- experimental_model
- Genetically engineered mice with established pancreatic tumors.
- limitations
- Not all tumors or normal tissues have the same dependency; dietary deprivation was not this intervention.
- nutrient_topic
- L-Cysteine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Cysteine
- plain_language
- A transporter dependency could be targeted in this animal cancer model.
- primary_references
- Cysteine depletion induces pancreatic tumor ferroptosis in mice. · 2020 · https://pubmed.ncbi.nlm.nih.gov/32241947/ · DOI 10.1126/science.aaw9872
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
L-Cysteine: sulfur allocation, redox supply and cross-nutrient mechanisms (2026-09-19) · lines 228–234
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Genetically engineered mice with established pancreatic tumors. · source_derived_draft · unverified_draft
## l-cysteine-mouse-pdac-import-loss A transporter dependency could be targeted in this animal cancer model. Deleting Slc7a11 in established genetically engineered mouse PDAC induced tumor-selective ferroptosis and inhibited growth. Model: Genetically engineered mice with established pancreatic tumors. Limitations: Not all tumors or normal tissues have the same dependency; dietary deprivation was not this intervention. Evidence access: Primary full text Cysteine depletion induces pancreatic tumor ferroptosis in mice. · 2020 · https://pubmed.ncbi.nlm.nih.gov/32241947/ · DOI 10.1126/science.aaw9872
Complete structured claim and evidenceSystem xc− inhibition lowered CoA and increased upstream pantothenate in the tested pancreatic cancer cells.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_access
- Primary full text
- experimental_model
- Human PDAC cultures with cystine-import inhibition and metabolomics.
- limitations
- Pantothenate accumulation is not proof of B5 toxicity or a clinical biomarker threshold.
- nutrient_topic
- L-Cysteine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Cysteine
- plain_language
- Vitamin B5 could accumulate while its downstream product fell because another substrate was missing.
- primary_references
- Cysteine depletion induces pancreatic tumor ferroptosis in mice. · 2020 · https://pubmed.ncbi.nlm.nih.gov/32241947/ · DOI 10.1126/science.aaw9872
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
L-Cysteine: sulfur allocation, redox supply and cross-nutrient mechanisms (2026-09-19) · lines 196–202
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human PDAC cultures with cystine-import inhibition and metabolomics. · source_derived_draft · unverified_draft
## l-cysteine-pdac-coa-branch Vitamin B5 could accumulate while its downstream product fell because another substrate was missing. System xc− inhibition lowered CoA and increased upstream pantothenate in the tested pancreatic cancer cells. Model: Human PDAC cultures with cystine-import inhibition and metabolomics. Limitations: Pantothenate accumulation is not proof of B5 toxicity or a clinical biomarker threshold. Evidence access: Primary full text Cysteine depletion induces pancreatic tumor ferroptosis in mice. · 2020 · https://pubmed.ncbi.nlm.nih.gov/32241947/ · DOI 10.1126/science.aaw9872
Complete structured claim and evidenceAdding CoA prevented ferroptosis induced by imidazole ketone erastin in the reported PDAC cell experiments.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_access
- Primary full text
- experimental_model
- Human PDAC culture and exogenous CoA treatment.
- limitations
- Cell-culture rescue does not establish oral CoA absorption, intact cellular uptake in vivo or clinical efficacy.
- nutrient_topic
- L-Cysteine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Cysteine
- plain_language
- Restoring a downstream metabolite bypassed part of an upstream block in culture.
- primary_references
- Cysteine depletion induces pancreatic tumor ferroptosis in mice. · 2020 · https://pubmed.ncbi.nlm.nih.gov/32241947/ · DOI 10.1126/science.aaw9872
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
L-Cysteine: sulfur allocation, redox supply and cross-nutrient mechanisms (2026-09-19) · lines 220–226
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human PDAC culture and exogenous CoA treatment. · source_derived_draft · unverified_draft
## l-cysteine-pdac-coa-rescue Restoring a downstream metabolite bypassed part of an upstream block in culture. Adding CoA prevented ferroptosis induced by imidazole ketone erastin in the reported PDAC cell experiments. Model: Human PDAC culture and exogenous CoA treatment. Limitations: Cell-culture rescue does not establish oral CoA absorption, intact cellular uptake in vivo or clinical efficacy. Evidence access: Primary full text Cysteine depletion induces pancreatic tumor ferroptosis in mice. · 2020 · https://pubmed.ncbi.nlm.nih.gov/32241947/ · DOI 10.1126/science.aaw9872
Complete structured claim and evidenceHuman SLC7A9 and SLC3A1 form the b0,+AT–rBAT obligatory exchanger for cystine/cationic amino-acid influx coupled to neutral amino-acid efflux.
Experimental context and source evidence
- evidence_access
- Primary full text
- experimental_model
- Human transporter cryo-EM and functional study; structural ligand was arginine.
- limitations
- Do not describe the arginine-bound structure as a captured cystine-bound state or infer dietary competition from binding alone.
- nutrient_topic
- L-Cysteine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Cysteine
- plain_language
- The kidney and intestine use a two-protein exchange system to handle cystine.
- primary_references
- Cryo-EM structure of the human heteromeric amino acid transporter b0,+AT-rBAT. · 2020 · https://pubmed.ncbi.nlm.nih.gov/32494597/ · DOI 10.1126/sciadv.aay6379
L-Cysteine: sulfur allocation, redox supply and cross-nutrient mechanisms (2026-09-19) · lines 20–26
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human transporter cryo-EM and functional study; structural ligand was arginine. · source_derived_draft · unverified_draft
## l-cysteine-renal-cystine-exchange The kidney and intestine use a two-protein exchange system to handle cystine. Human SLC7A9 and SLC3A1 form the b0,+AT–rBAT obligatory exchanger for cystine/cationic amino-acid influx coupled to neutral amino-acid efflux. Model: Human transporter cryo-EM and functional study; structural ligand was arginine. Limitations: Do not describe the arginine-bound structure as a captured cystine-bound state or infer dietary competition from binding alone. Evidence access: Primary full text Cryo-EM structure of the human heteromeric amino acid transporter b0,+AT-rBAT. · 2020 · https://pubmed.ncbi.nlm.nih.gov/32494597/ · DOI 10.1126/sciadv.aay6379
Complete structured claim and evidenceTXNDC17 knockout in human HEK293 cells markedly reduced intracellular cystine reduction; wild-type TRP14 re-expression restored activity whereas its active-site mutant did not.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_access
- Primary full text
- experimental_model
- Human HEK293 knockout/rescue; fluorescent cystine-reduction assays.
- limitations
- The paper identifies a major rate-limiting route in tested systems, not the only possible reductase in every tissue.
- nutrient_topic
- L-Cysteine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Cysteine
- plain_language
- Importing oxidized cysteine is not enough: the cell must reduce it to use it.
- primary_references
- TRP14 is the rate-limiting enzyme for intracellular cystine reduction and regulates proteome cysteinylation. · 2024 · https://pubmed.ncbi.nlm.nih.gov/38811853/ · DOI 10.1038/s44318-024-00117-1
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
L-Cysteine: sulfur allocation, redox supply and cross-nutrient mechanisms (2026-09-19) · lines 60–66
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human HEK293 knockout/rescue; fluorescent cystine-reduction assays. · source_derived_draft · unverified_draft
## l-cysteine-trp14-cystine-reduction Importing oxidized cysteine is not enough: the cell must reduce it to use it. TXNDC17 knockout in human HEK293 cells markedly reduced intracellular cystine reduction; wild-type TRP14 re-expression restored activity whereas its active-site mutant did not. Model: Human HEK293 knockout/rescue; fluorescent cystine-reduction assays. Limitations: The paper identifies a major rate-limiting route in tested systems, not the only possible reductase in every tissue. Evidence access: Primary full text TRP14 is the rate-limiting enzyme for intracellular cystine reduction and regulates proteome cysteinylation. · 2024 · https://pubmed.ncbi.nlm.nih.gov/38811853/ · DOI 10.1038/s44318-024-00117-1
Complete structured claim and evidenceThe reconstituted TRP14 system used thioredoxin reductase 1 and NADPH to drive disulfide-reduction reactions.
Experimental context and source evidence
- evidence_access
- Primary full text
- experimental_model
- Purified enzyme systems, including human peroxiredoxin-2 decysteinylation.
- limitations
- This establishes a biochemical dependency; selenium or niacin depletion/repletion was not tested in this study.
- nutrient_topic
- L-Cysteine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Cysteine
- plain_language
- The sulfur-supply step depends on an electron supply and another enzyme.
- primary_references
- TRP14 is the rate-limiting enzyme for intracellular cystine reduction and regulates proteome cysteinylation. · 2024 · https://pubmed.ncbi.nlm.nih.gov/38811853/ · DOI 10.1038/s44318-024-00117-1
L-Cysteine: sulfur allocation, redox supply and cross-nutrient mechanisms (2026-09-19) · lines 68–74
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Purified enzyme systems, including human peroxiredoxin-2 decysteinylation. · source_derived_draft · unverified_draft
## l-cysteine-trp14-electron-supply The sulfur-supply step depends on an electron supply and another enzyme. The reconstituted TRP14 system used thioredoxin reductase 1 and NADPH to drive disulfide-reduction reactions. Model: Purified enzyme systems, including human peroxiredoxin-2 decysteinylation. Limitations: This establishes a biochemical dependency; selenium or niacin depletion/repletion was not tested in this study. Evidence access: Primary full text TRP14 is the rate-limiting enzyme for intracellular cystine reduction and regulates proteome cysteinylation. · 2024 · https://pubmed.ncbi.nlm.nih.gov/38811853/ · DOI 10.1038/s44318-024-00117-1
Complete structured claim and evidenceLowering culture-medium cystine mimicked glutamate-associated glutathione loss and oxidative cytotoxicity in N18-RE-105 cells.
Experimental context and source evidence
- availability_state
- nutrient_deficiency Imported condition classification; unverified.
- evidence_access
- Primary abstract
- experimental_model
- Neuronal hybrid-cell nutrient-withdrawal experiment.
- limitations
- The deficient precursor is cystine/cysteine supply, not glutamate; no human dietary threshold is established.
- nutrient_topic
- L-Glutamate collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Glutamate
- plain_language
- Removing the missing precursor reproduced the supply failure.
- primary_references
- Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress. · 1989 · https://pubmed.ncbi.nlm.nih.gov/2576375/ · DOI 10.1016/0896-6273(89)90043-3
- trigger_kind
- nutrient_deficiency Imported condition classification; unverified.
L-Glutamate / L-glutamic acid: carbon and nitrogen allocation, signaling and cross-nutrient mechanisms (2026-09-19) · lines 346–352
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Neuronal hybrid-cell nutrient-withdrawal experiment. · source_derived_draft · unverified_draft
## glutamate-cystine-shortage Removing the missing precursor reproduced the supply failure. Lowering culture-medium cystine mimicked glutamate-associated glutathione loss and oxidative cytotoxicity in N18-RE-105 cells. Model: Neuronal hybrid-cell nutrient-withdrawal experiment. Limitations: The deficient precursor is cystine/cysteine supply, not glutamate; no human dietary threshold is established. Evidence access: Primary abstract Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress. · 1989 · https://pubmed.ncbi.nlm.nih.gov/2576375/ · DOI 10.1016/0896-6273(89)90043-3
Complete structured claim and evidenceAdded extracellular glutamate inhibited cystine uptake in N18-RE-105 neuronal hybrid cells, and toxicity tracked that inhibition.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Neuroblastoma/primary-retina hybrid-cell culture; transport and toxicity assays.
- limitations
- The early paper does not genetically resolve SLC7A11; it is not an oral glutamate exposure study.
- nutrient_topic
- L-Glutamate collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Glutamate
- plain_language
- The same molecule used to build an antioxidant can obstruct another required ingredient when outside these cells.
- primary_references
- Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress. · 1989 · https://pubmed.ncbi.nlm.nih.gov/2576375/ · DOI 10.1016/0896-6273(89)90043-3
L-Glutamate / L-glutamic acid: carbon and nitrogen allocation, signaling and cross-nutrient mechanisms (2026-09-19) · lines 330–336
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Neuroblastoma/primary-retina hybrid-cell culture; transport and toxicity assays. · source_derived_draft · unverified_draft
## glutamate-extracellular-cystine-block The same molecule used to build an antioxidant can obstruct another required ingredient when outside these cells. Added extracellular glutamate inhibited cystine uptake in N18-RE-105 neuronal hybrid cells, and toxicity tracked that inhibition. Model: Neuroblastoma/primary-retina hybrid-cell culture; transport and toxicity assays. Limitations: The early paper does not genetically resolve SLC7A11; it is not an oral glutamate exposure study. Evidence access: Primary abstract Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress. · 1989 · https://pubmed.ncbi.nlm.nih.gov/2576375/ · DOI 10.1016/0896-6273(89)90043-3
Complete structured claim and evidenceExtracellular glutamate exposure lowered glutathione and increased intracellular peroxides in N18-RE-105 cells alongside inhibited cystine uptake.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Neuronal hybrid-cell transport, glutathione and peroxide assays.
- limitations
- A specific experimental toxicity mechanism is retained without inferring normal food-related brain injury.
- nutrient_topic
- L-Glutamate collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Glutamate
- plain_language
- Oxidative injury arose through precursor supply, a different route from opening an excitatory receptor.
- primary_references
- Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress. · 1989 · https://pubmed.ncbi.nlm.nih.gov/2576375/ · DOI 10.1016/0896-6273(89)90043-3
L-Glutamate / L-glutamic acid: carbon and nitrogen allocation, signaling and cross-nutrient mechanisms (2026-09-19) · lines 338–344
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Neuronal hybrid-cell transport, glutathione and peroxide assays. · source_derived_draft · unverified_draft
## glutamate-extracellular-gsh-loss Oxidative injury arose through precursor supply, a different route from opening an excitatory receptor. Extracellular glutamate exposure lowered glutathione and increased intracellular peroxides in N18-RE-105 cells alongside inhibited cystine uptake. Model: Neuronal hybrid-cell transport, glutathione and peroxide assays. Limitations: A specific experimental toxicity mechanism is retained without inferring normal food-related brain injury. Evidence access: Primary abstract Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress. · 1989 · https://pubmed.ncbi.nlm.nih.gov/2576375/ · DOI 10.1016/0896-6273(89)90043-3
Complete structured claim and evidenceSulfite reacted stoichiometrically with cystine to form SSC; reduced cysteine did not form SSC in the same assay.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_span
- {"source_cache": "artifacts/molybdenum-research/29106383.fulltext.txt", "locator": "Exact primary full-text span; zero-based, end-exclusive Unicode character offsets", "file_sha256": "d7cfb311498ba2a88e3fc04be988dcffda740bbd1d93ada686cabf801861cf2a", "start_char": 14310, "end_char": 15490, "text_sha256": "9a181fcee8488d6f7513a0fa1759320721a8663e58658ef9344c1354716e3284"}
- experimental_model
- Primary murine neurons, chemical reaction assays and tungstate-induced MoCD mice
- exposure
- SSC/sulfite exposure; receptor/calcium/calpain inhibition
- limitations
- Mechanistic model evidence. Mouse drug rescue does not establish human treatment efficacy; sulfite also has SSC-independent toxicity.
- nutrient_topic
- Molybdenum research collection; topical membership is not evidence of a direct dietary effect. · Molybdenum
- organism
- Mus musculus neurons and mice; chemical reaction assays
- plain_language
- The oxidized and reduced forms of cysteine behave differently.
- primary_references
- [mo-p29106383] S-sulfocysteine/NMDA receptor-dependent signaling underlies neurodegeneration in molybdenum cofactor deficiency. (2017). https://pubmed.ncbi.nlm.nih.gov/29106383/ DOI: 10.1172/jci89885
- tissue_or_cell_type
- Neuronal receptors, intracellular calcium and inhibitory synapses
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Molybdenum: cofactor assembly, sulfur metabolism and nutrient interactions (2026-09-17) · lines 1236–1247
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Primary murine neurons, chemical reaction assays and tungstate-induced MoCD mice · source_derived_draft · unverified_draft
### mo-ssc-formation Sulfite reacted stoichiometrically with cystine to form SSC; reduced cysteine did not form SSC in the same assay. Condition category: machinery_impairment nutrient_topic: Molybdenum research collection; topical membership is not evidence of a direct dietary effect. plain_language: The oxidized and reduced forms of cysteine behave differently. organism: Mus musculus neurons and mice; chemical reaction assays tissue_or_cell_type: Neuronal receptors, intracellular calcium and inhibitory synapses experimental_model: Primary murine neurons, chemical reaction assays and tungstate-induced MoCD mice limitations: Mechanistic model evidence. Mouse drug rescue does not establish human treatment efficacy; sulfite also has SSC-independent toxicity. exposure: SSC/sulfite exposure; receptor/calcium/calpain inhibition evidence_span: {"source_cache": "artifacts/molybdenum-research/29106383.fulltext.txt", "locator": "Exact primary full-text span; zero-based, end-exclusive Unicode character offsets", "file_sha256": "d7cfb311498ba2a88e3fc04be988dcffda740bbd1d93ada686cabf801861cf2a", "start_char": 14310, "end_char": 15490, "text_sha256": "9a181fcee8488d6f7513a0fa1759320721a8663e58658ef9344c1354716e3284"} [mo-p29106383] S-sulfocysteine/NMDA receptor-dependent signaling underlies neurodegeneration in molybdenum cofactor deficiency. (2017). https://pubmed.ncbi.nlm.nih.gov/29106383/ DOI: 10.1172/jci89885
Complete structured claim and evidenceThe cysteamine-cysteine mixed disulfide left treated cystinotic fibroblasts, contributing to depletion of accumulated cellular cystine.
Experimental context and source evidence
- cross_nutrient
- false
- evidence_location
- Primary indexed abstract, including metabolite-tracing conclusion.
- experimental_model
- Radiolabeled cystine metabolite-tracing experiment in cultured patient fibroblasts
- exposure
- Pantethine or cystamine treatment; specific concentration not retrieved from the primary abstract.
- limitations
- Disease-derived cultured cells; no molecular exporter is assigned without evidence. Formation and efflux of a mixed disulfide do not prove that pantothenate alone treats cystinosis.
- nutrient_topic
- Pantothenic acid (vitamin B5) research collection; topical membership is not evidence of a direct dietary effect. · Pantothenate (vitamin B5)
- organism
- Homo sapiens
- plain_language
- Export of the new disulfide helped remove the stored cystine.
- primary_references
- [b5-clin-butler1984] Pantethine and cystamine deplete cystine from cystinotic fibroblasts via efflux of cysteamine-cysteine mixed disulfide. (1984). https://pubmed.ncbi.nlm.nih.gov/6746900/ DOI: 10.1172/jci111436
- tissue_or_cell_type
- Cystinotic fibroblast lysosomes and extracellular medium
Pantothenic acid (vitamin B5): coenzyme A, deficiency and nutrient interactions (2026-09-17) · lines 1509–1521
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Radiolabeled cystine metabolite-tracing experiment in cultured patient fibroblasts · source_derived_draft · unverified_draft
### b5-clin-mixed-disulfide-efflux The cysteamine-cysteine mixed disulfide left treated cystinotic fibroblasts, contributing to depletion of accumulated cellular cystine. Condition category: normal nutrient_topic: Pantothenic acid (vitamin B5) research collection; topical membership is not evidence of a direct dietary effect. plain_language: Export of the new disulfide helped remove the stored cystine. organism: Homo sapiens tissue_or_cell_type: Cystinotic fibroblast lysosomes and extracellular medium experimental_model: Radiolabeled cystine metabolite-tracing experiment in cultured patient fibroblasts limitations: Disease-derived cultured cells; no molecular exporter is assigned without evidence. Formation and efflux of a mixed disulfide do not prove that pantothenate alone treats cystinosis. exposure: Pantethine or cystamine treatment; specific concentration not retrieved from the primary abstract. cross_nutrient: false evidence_location: Primary indexed abstract, including metabolite-tracing conclusion. [b5-clin-butler1984] Pantethine and cystamine deplete cystine from cystinotic fibroblasts via efflux of cysteamine-cysteine mixed disulfide. (1984). https://pubmed.ncbi.nlm.nih.gov/6746900/ DOI: 10.1172/jci111436
Complete structured claim and evidenceRadiolabeled cystine tracing in cystinotic fibroblasts supported formation of cysteamine-cysteine mixed disulfide during pantethine treatment.
Experimental context and source evidence
- cross_nutrient
- false
- evidence_location
- Primary indexed abstract, including metabolite-tracing conclusion.
- experimental_model
- Radiolabeled cystine metabolite-tracing experiment in cultured patient fibroblasts
- exposure
- Pantethine or cystamine treatment; specific concentration not retrieved from the primary abstract.
- limitations
- Disease-derived cultured cells; no molecular exporter is assigned without evidence. Formation and efflux of a mixed disulfide do not prove that pantothenate alone treats cystinosis.
- nutrient_topic
- Pantothenic acid (vitamin B5) research collection; topical membership is not evidence of a direct dietary effect. · Pantothenate (vitamin B5)
- organism
- Homo sapiens
- plain_language
- The derivative changed accumulated cystine into a different disulfide product in these patient cells.
- primary_references
- [b5-clin-butler1984] Pantethine and cystamine deplete cystine from cystinotic fibroblasts via efflux of cysteamine-cysteine mixed disulfide. (1984). https://pubmed.ncbi.nlm.nih.gov/6746900/ DOI: 10.1172/jci111436
- tissue_or_cell_type
- Cystinotic fibroblast lysosomes and extracellular medium
Pantothenic acid (vitamin B5): coenzyme A, deficiency and nutrient interactions (2026-09-17) · lines 1495–1507
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Radiolabeled cystine metabolite-tracing experiment in cultured patient fibroblasts · source_derived_draft · unverified_draft
### b5-clin-pantethine-mixed-disulfide Radiolabeled cystine tracing in cystinotic fibroblasts supported formation of cysteamine-cysteine mixed disulfide during pantethine treatment. Condition category: normal nutrient_topic: Pantothenic acid (vitamin B5) research collection; topical membership is not evidence of a direct dietary effect. plain_language: The derivative changed accumulated cystine into a different disulfide product in these patient cells. organism: Homo sapiens tissue_or_cell_type: Cystinotic fibroblast lysosomes and extracellular medium experimental_model: Radiolabeled cystine metabolite-tracing experiment in cultured patient fibroblasts limitations: Disease-derived cultured cells; no molecular exporter is assigned without evidence. Formation and efflux of a mixed disulfide do not prove that pantothenate alone treats cystinosis. exposure: Pantethine or cystamine treatment; specific concentration not retrieved from the primary abstract. cross_nutrient: false evidence_location: Primary indexed abstract, including metabolite-tracing conclusion. [b5-clin-butler1984] Pantethine and cystamine deplete cystine from cystinotic fibroblasts via efflux of cysteamine-cysteine mixed disulfide. (1984). https://pubmed.ncbi.nlm.nih.gov/6746900/ DOI: 10.1172/jci111436
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.